Simultaneous bilateral ureteral stones, although rare (1–3%) among urinary stone diseases, represent a clinically critical condition that can present with anuria and acute renal failure. Historically, it was thought that surgical intervention to both sides in these cases carried risks of bilateral ureteral edema and loss of renal function; however, modern endourological equipment and increasing surgical experience have shown that same-session bilateral ureteroscopy can be performed safely(4,5). Our series of 80 patients is one of the largest single-center B-URS studies in the literature, proving both the high success and safety of the procedure.
Comprehensive meta-analyses in the literature report total stone-free rates (SFR) after B-URS between 87% and 95%(9,11). The total stone-free rate of 96.25% obtained in our series is at the upper limit of these data. One of the most important factors affecting success is the anatomical localization of the stone in the ureter. In the meta-analysis performed by Ge et al., SFR was 96% in the distal ureter, while this rate decreased to 72% for stones located proximally (9). Despite a high rate of bilateral proximal stones (27.5%) in our series, high success rates consistent with the literature were achieved using laser lithotripsy and appropriate surgical techniques.
The main concern regarding bilateral ureteroscopy is the risk of major surgical complications. Although complication rates up to 29% were reported in past series using large-caliber (>10 Fr) devices (12), this rate has decreased to 10–17% in current literature (4,9). The 12.5% complication rate observed in our series is parallel with the safety data (15–16%) in the CROES Global study presented by Pace et al. (13). Most importantly, the absence of major (Grade III-IV) complications, such as ureteral perforation or avulsion in our series, confirms that B-URS is as safe as unilateral interventions in selected cases.
The literature reports that rapid relief of obstruction preserves renal functions and normalizes creatinine levels. In our series, the significant decrease of -0.20 mg/dL (p < 0.001) from a preoperative creatinine level of 1.16 mg/dL demonstrates that B-URS is not only a stone-clearing procedure but also a renal function-saving one.
The greatest advantage of B-URS compared to staged surgery is that the patient is cleared of the stone burden in a single anesthesia session and the total hospital stay is reduced. In addition to reducing operative burden and hospitalization, same-session treatment eliminates the need for a second anesthetic exposure and improves patient satisfaction by avoiding repeated hospital admissions and cumulative stent-related symptoms. Fiscus et al. demonstrated that single-session bilateral surgery significantly reduces operative time and costs (14). The median operative time of 60 minutes in our series is consistent with the 45–100 minute range reported in meta-analyses (9). This efficiency contributes to reducing the burden on the healthcare system, particularly in high-volume centers.
The main limitations of our study are its retrospective design, the reflection of a single-center experience, and the relatively small patient population. Additionally, the lack of direct comparison between our B-URS results and staged bilateral procedures is another limitation. The lack of routine computed tomography for evaluating stone-free rates in every case and the inability to perform stone composition analysis and stone density (HU) measurements in all patients limit the detailed analysis of our results. Finally, longer-term follow-up data are needed to detect rare late-term complications such as ureteral stricture.
DISCUSSION
Simultaneous bilateral ureteral stones, although rare (1–3%) among urinary stone diseases, represent a clinically critical condition that can present with anuria and acute renal failure. Historically, it was thought that surgical intervention to both sides in these cases carried risks of bilateral ureteral edema and loss of renal function; however, modern endourological equipment and increasing surgical experience have shown that same-session bilateral ureteroscopy can be performed safely(4,5). Our series of 80 patients is one of the largest single-center B-URS studies in the literature, proving both the high success and safety of the procedure.
Comprehensive meta-analyses in the literature report total stone-free rates (SFR) after B-URS between 87% and 95%(9,11). The total stone-free rate of 96.25% obtained in our series is at the upper limit of these data. One of the most important factors affecting success is the anatomical localization of the stone in the ureter. In the meta-analysis performed by Ge et al., SFR was 96% in the distal ureter, while this rate decreased to 72% for stones located proximally (9). Despite a high rate of bilateral proximal stones (27.5%) in our series, high success rates consistent with the literature were achieved using laser lithotripsy and appropriate surgical techniques.
The main concern regarding bilateral ureteroscopy is the risk of major surgical complications. Although complication rates up to 29% were reported in past series using large-caliber (>10 Fr) devices (12), this rate has decreased to 10–17% in current literature (4,9). The 12.5% complication rate observed in our series is parallel with the safety data (15–16%) in the CROES Global study presented by Pace et al. (13). Most importantly, the absence of major (Grade III-IV) complications, such as ureteral perforation or avulsion in our series, confirms that B-URS is as safe as unilateral interventions in selected cases.
The literature reports that rapid relief of obstruction preserves renal functions and normalizes creatinine levels. In our series, the significant decrease of -0.20 mg/dL (p < 0.001) from a preoperative creatinine level of 1.16 mg/dL demonstrates that B-URS is not only a stone-clearing procedure but also a renal function-saving one.
The greatest advantage of B-URS compared to staged surgery is that the patient is cleared of the stone burden in a single anesthesia session and the total hospital stay is reduced. In addition to reducing operative burden and hospitalization, same-session treatment eliminates the need for a second anesthetic exposure and improves patient satisfaction by avoiding repeated hospital admissions and cumulative stent-related symptoms. Fiscus et al. demonstrated that single-session bilateral surgery significantly reduces operative time and costs (14). The median operative time of 60 minutes in our series is consistent with the 45–100 minute range reported in meta-analyses (9). This efficiency contributes to reducing the burden on the healthcare system, particularly in high-volume centers.
The main limitations of our study are its retrospective design, the reflection of a single-center experience, and the relatively small patient population. Additionally, the lack of direct comparison between our B-URS results and staged bilateral procedures is another limitation. The lack of routine computed tomography for evaluating stone-free rates in every case and the inability to perform stone composition analysis and stone density (HU) measurements in all patients limit the detailed analysis of our results. Finally, longer-term follow-up data are needed to detect rare late-term complications such as ureteral stricture.